You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ATG PK

Showing 1 - 25 of 6,930
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors, B-cell Non-Hodgkin Lymphomas Trial (ATG-031)

Not yet recruiting
  • Advanced Solid Tumors
  • B-cell Non-Hodgkin Lymphomas
  • (no location specified)
Aug 31, 2023

Solid Tumor, Hematological Malignancy Trial in Australia (ATG-017)

Recruiting
  • Solid Tumor
  • Hematological Malignancy
  • East Melbourne, Victoria, Australia
  • +4 more
Jan 11, 2023

Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in China (ATG-010 and ATG-008)

Recruiting
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma
  • ATG-010 and ATG-008
  • Chongqing, Chongqing, China
  • +5 more
Sep 2, 2022

Severe Aplastic Anemia (SAA) Trial in Worldwide (eltrombopag, rabbit anti-thymocyte globulin (r-ATG), cyclosporine A (CsA))

Active, not recruiting
  • Severe Aplastic Anemia (SAA)
  • Zhengzhou, Henan, China
  • +11 more
Jan 23, 2023

Acute Myeloid Leukemia (AML), Acute Lymphoid Leukemia (ALL), MDS (MDS) Trial in New York (other, radiation, drug)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Personalized rATG (P-rATG)
  • +7 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 31, 2022

Relapse/Refractory Multiple Myeloma Trial in China (ATG-010)

Completed
  • Relapse/Refractory Multiple Myeloma
  • Beijing, Beijing, China
  • +16 more
Jul 27, 2022

Advanced Solid Tumors, Hematological Malignancies Trial (ATG-018)

Not yet recruiting
  • Advanced Solid Tumors
  • Hematological Malignancies
  • (no location specified)
Apr 14, 2022

Acute Myeloid Leukemia in Remission, MDS, Chronic Myeloid Leukemia in Remission Trial in Belgium (Thymoglobulin, Melphalan,

Recruiting
  • Acute Myeloid Leukemia in Remission
  • +9 more
  • Antwerp, Belgium
  • +9 more
Oct 5, 2021

Hematologic Malignancies Trial in New York (Busulfan 3.2 mg/kg/day, Fludarabine, Melphalan)

Recruiting
  • Hematologic Malignancies
  • Busulfan 3.2 mg/kg/day
  • +5 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 14, 2022

Acromegaly, GEP-NET Trial in Worldwide (Debio 4126, Sandostatin LAR, Somatuline ATG)

Recruiting
  • Acromegaly
  • GEP-NET
  • Debio 4126
  • +2 more
  • Copenaghen, Denmark
  • +34 more
Jan 27, 2023

Multiple Myeloma Trial in Guangzhou (Selinexor, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Guangzhou, Guangdong, China
  • +3 more
Aug 16, 2022

Aplastic Anemia Trial in Worldwide (Eltrombopag, hATG, CsA)

Active, not recruiting
  • Aplastic Anemia
  • Phoenix, Arizona
  • +19 more
Jan 19, 2023

Sickle Cell Disease, Thalassemia, Beta, Thalassemia Trial in United States (Fludarabine, Cyclophosphamide, Tacrolimus)

Recruiting
  • Sickle Cell Disease
  • +2 more
  • Basking Ridge, New Jersey
  • +5 more
Feb 17, 2023

Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)

Not yet recruiting
  • Severe Aplastic Anemia
  • (no location specified)
Oct 1, 2023

Hematologic Malignancy Trial (Cyclophosphamid, ATG)

Not yet recruiting
  • Hematologic Malignancy
  • (no location specified)
Oct 29, 2023

Aplastic Anemia Trial in Beijing (Ciclosporin, Avatrombopag, Anti-Human Thymocyte Immunoglobulin, Rabbit)

Not yet recruiting
  • Aplastic Anemia
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

De Novo Kidney Transplant Patients Trial in China (ATG-F)

Completed
  • De Novo Kidney Transplant Patients
  • Beijing, China
  • +13 more
Jul 26, 2022

GVHD Trial (Grafalon, Thymoglobulin)

Not yet recruiting
  • GVHD
  • (no location specified)
Oct 9, 2023

Aplastic Anemia Trial in Beijing (Avatrombopag+CsA)

Not yet recruiting
  • Aplastic Anemia
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

The Optimization of Haploidentical Hematopoietic Stem Cell

Not yet recruiting
  • Hematological Malignancy
  • ATG
  • Post-transplantation cyclophosphamide
  • Beijing, Beijing, China
    People's Hospital of Peking University
Nov 28, 2022

Graft-versus-host-disease, Relapse Trial in Calgary (Treatment Arm - high dose ATG, Control Arm - standard of care)

Recruiting
  • Graft-versus-host-disease
  • Relapse
  • Treatment Arm - high dose ATG
  • Control Arm - standard of care
  • Calgary, Alberta, Canada
    Tom Baker Cancer Centre
Oct 14, 2022

Severe Aplastic Anemia Trial in Hefei (Anti-Thymocyte Globulin (Rabbit))

Recruiting
  • Severe Aplastic Anemia
  • Anti-Thymocyte Globulin (Rabbit)
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Sep 9, 2023

Cutaneous T-cell Lymphoma, T-Prolymphocytic Leukemia, T-Large Granulocytic Leukemia Trial in Columbus (Romidepsin, Busulfan,

Recruiting
  • Cutaneous T-cell Lymphoma
  • +4 more
  • Columbus, Ohio
    The Ohio State University Cancer Center
Apr 18, 2022

Advanced/Metastatic Solid Tumors Trial in Australia, China (ATG-022)

Not yet recruiting
  • Advanced/Metastatic Solid Tumors
  • Adelaide, Australia
  • +3 more
Jan 30, 2023

Multiple Myeloma Trial in Zhengzhou, Wuhan, Xi'an (Selinexor (80mg/d), Selinexor (100mg/d), Pegylated liposomal doxorubicin)

Recruiting
  • Multiple Myeloma
  • Selinexor (80mg/d)
  • +4 more
  • Zhengzhou, Henan, China
  • +4 more
Aug 16, 2022